The International Neuromodulation Society

The Fastest-Growing, Worldwide Multidisciplinary Body Devoted to Building Knowledge of Neuromodulation

The International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation – the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body. The San Francisco-based INS was formed in 1989 and educates and promotes the field through meetings, its peer-reviewed journal Neuromodulation: Technology at the Neural Interface, explanatory content, and chapter websites. The INS also provides information for patients and produces rolling news briefs about this rapidly evolving field.

The INS Peer-Reviewed Journal – 8 Issues a Year

The INS journal Neuromodulation: Technology at the Neural Interface has a growing Impact Factor and is indexed in Index Medicus, MEDLINE and Pubmed from its first issue in 1998. Members may log in to the members-only section to read the journal online.

journal cover

+Submit a Manuscript.+


What is Neuromodulation?

Medical Professionals can learn about various considerations concerning neuromodulation and clinic contacts. Once your preliminary questions have been answered, please use the Contact Us facility to find out more and to discuss specific objectives. Others may simply wish to join the INS and one of its related chapter societies, please use the Membership Application.

Clinical trials that involve a wide range of emerging neuromodulation approaches are listed on our Research page. Neuromodulation clinical trials address symptom control through nerve stimulation in such condition categories as:

If you are not a medical professional and you are searching for information about neuromodulation and how these types of treatment could benefit a specific condition such as treatment-resistant headache or other chronic pain syndromes, you may find the sections titled Therapies, About Neuromodulation or FAQs particularly helpful.

Members may log in and visit the members-only section’s Global Discussion Forum

Breaking News Share

Release Describes Chronic Pain Patient's Journey and the Role of Neuromodulation Therapy

May 15, 2019 - A preconference of the International Neuromodulation Society 14th World Congress will include presentations from experts and patients on neuromodulation for chronic pain, bladder conditions, and movement disorder. A news release previews the story of a chronic pain patient who will speak, and provides background information about neuromodulation therapy and neurostimulation for chronic pain in Australia. (Scimex)

Review: Current Perspectives on Deep Brain Stimulation in Obsessive Compulsive Disorder

May 15, 2019 - A review considers current perspectives on deep brain stimulation in the treatment of obsessive compulsive disorder. (Neuropsychiatric Disease and Treatment)

Company Partners with U.S. National Institutes of Health Neuroscience Initiative

May 14, 2019 - Abbott announced it is partnering with the U.S. BRAIN Initiative by providing its neuromodulation technologies for research related to chronic pain and movement disorder. (Medtech Dive)

Study Examines Influence of Weight on Pain Relief from Spinal Cord Stimulation

May 14, 2019 - A study reports spinal cord stimulation outcomes in the context of patients' body-mass index. (Pain Medicine News)

West Virginia Neuroscience Institute Prepares for Clinical Trial of Deep Brain Stimulation in Drug Addiction

May 14, 2019 - The West Virginia University Medicine Rockefeller Neuroscience Institute received FDA approval for a clinical trial of deep brain stimulation in drug addiction. (The Exponent Telegram)

New TMS Approach Offered in North Carolina for Obsessive Compulsive Disorder

May 14, 2019 - A North Carolina private medical practice will offer deep transcranial magnetic stimulation (TMS) for obsessive compulsive disorder. (WRAL TechWire)

Company's Peripheral Nerve Stimulator Implanted in Australia

May 13, 2019 - Bioness, Inc. announced its first successful implantation of its peripheral nerve stimulator in a pain patient in Australia. (P&T Community)


To see select neuromodulation news by category, as well as news about the INS in particular, please visit the Newsroom. To see archived news briefs dating back to January 2011, visit the News Archive.

Continue Reading News Briefs
Last Updated on Monday, December 12, 2016 10:01 AM